Vascular biology support for the use of bevacizumab in colorectal cancer

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.6, 2004-06, pp. : 703-705

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab: A Review of its Use in Metastatic Colorectal Cancer

By McCormack Paul L. Keam Susan J.

Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. : 487-506

Adis International

Access to resources Recommend Favorite

Use of Bevacizumab in Metastatic Colorectal Cancer: Report from the Mexican Opinion and Analysis Forum on Colorectal Cancer Treatment with Bevacizumab (September 2009)

By Zinser-Sierra Juan W.

Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. : 101-111

Adis International

Access to resources Recommend Favorite

Bevacizumab in colorectal cancer: profile report

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 5, 2005-05 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor (VEGF) as a Target of Bevacizumab in Cancer: From the Biology to the Clinic

Current Medicinal Chemistry, Vol. 13, Iss. 16, 2006-07 ,pp. : 1845-1857

Bentham Science Publishers

Access to resources Recommend Favorite

Bevacizumab an improvement on standard therapy in colorectal cancer

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite